SUMMARY We used contrast echocardiography to estimate changes in flow velocity at the tricuspid and pulmonic valve orifices, as reflected by varying angles of the moving linear contrast echoes. The validity of the method was established by catheterization and echocardiographic studies in 14 patients. Flow velocity at the tricuspid and pulmonic valve orifices was measured by means of an electromagnetic flow-velocity probe, and the contrast echocardiogram was recorded simultaneously. Instantaneous changes in contrast flow velocity as measured by the contrast echo angle correlated significantly with flow velocity changes measured by the probe at the tricuspid valve orifice (mean r = 0.87) and at the pulmonic valve orifice (mean r = 0.92).
KNOWLEDGE of flow velocity is clinically important in the evaluation of heart function.1 Flow velocity can be measured invasively and noninvasively, using, for example, the electromagnetic catheter-tip flow-velocity probe and the Doppler method. The latter method, however, presents technical problems for the measurement of flow velocity.8' Therefore, we developed a relatively simple and reliable technique for measuring flow velocity noninvasively, using M-mode contrast echocardiography.
Based on the principle underlying the contrast effect, 10-12 we hypothesized that the particle (microbubble) moves midstream in the blood flow through either valve approximately parallel to the ultrasonic beam, producing a linear contrast echo. If the contrast echo is drawn as a straight line at a predetermined period of limited duration, it may be possible to use this line to determine flow velocity as the ratio of time and distance.
In this study we evaluated the usefulness of contrast echocardiography in calculating changes in flow velocity in the right side of the heart.
Materials and Methods The present series consists of 12 normal male subjects (mean age 28 years, range 26-31 years) and 14 patients with heart disease (five males and nine females, mean age 40 years, range 28-55 years) who were diagnosed by cardiac catheterization (table 1) .
In the contrast technique, the participants received two to 10 injections that consisted of 1 ml of indocyanine green and 10 ml of saline into an antecubital vein over a period of one or several days. The linear contrast echo was recorded at the tricuspid or pulmonic valve orifice during quiet respiration. In theory, successful recording of the linear contrast echo depends primarily upon directing the ultrasonic beam so that it forms an almost 1800 (0°) angle with the midstream blood flow through either valve. However, because the blood flow through the tricuspid valve orifice is multidirectional and the direction of the midstream blood flow may change with varying shapes of the right ventricle in different patients, it would not be as easy to determine a reasonable echo direction to ensure that the beam would parallel the midstream blood flow through the tricuspid valve orifice. We therefore selected the tip of the anterior leaflet of the valve as a suitable reference point that could be visualized in the parasternal four-chamber view by means of two-dimensional echocardiography using a Abbreviations: CCM = congestive cardiomyopathy. AI = aortic insufficiency; MISI = mitral stenosis and insufficiency; ASI = aortic stenosis and insufficiency; HCM = hypertrophic cardiomvopathv; ASD = atrial septal defect; PH = pulmonary hypertension; AF = atrial fibrillation; CFV =-contrast flow velocity; FV = flow velocity; TV= tricuspid valve; PV = pulmonic valve.
phased-array electrical sector scanner (Toshiba SSH-1 A) or a mechanical sector scanner (Smith-Kline Instruments, EkoSector I). To direct the ultrasonic beam as nearly parallel to the long axis of the right ventricle as possible, a nonfocused, 13-mm-diameter, 2.25-MHz) transducer (Electronics for Medicine) was placed in the third or fourth intercostal space near the left sternal border and angled medially so that the tip of the tricuspid valve being recorded was the fastest anterior motion in the rapid-filling phase and the length of the linear contrast echo recorded was the longest possible. The interatrial septum13 16 at times was recorded below the valve.
To direct the beam parallel to the flow through the pulmonic valve orifice, the transducer was placed in the third or fourth intercostal space and angled superiorly so that the direction of the ultrasonic beam paralleled the long axis of the main pulmonary artery as imaged by two-dimensional echocardiography and the recorded length of the linear contrast echo was again the longest possible. In this echo direction, no multiple echoes just below the pulmonic valve were recorded in systole and the rapid posterior motion of the tip of the valve in the early ejection phase was recorded.
In the invasive flow-velocity technique, flow velocity was measured in all 14 patients with a Millar electromagnetic catheter-tip flow-velocity probe that had a flexible guide approximately 4 cm long distal to the flow sensor, and was inserted through the antecubital or saphenous vein into the tricuspid or pulmonic valve orifice, respectively. To record the flow-velocity curve at the tricuspid valve orifice, the tip of the guide was manipulated to touch the right ventricular wall so that the sensor was positioned in the tricuspid valve orifice and the maximal and biphasic forward flow-velocity patterns during the diastolic phase could be recorded. To record the flow-velocity curve at the pulmonic valve orifice, we positioned the catheter so that the sensor was positioned in the pulmonic valve orifice and the maximal forward flow-velocity pattern during the systolic phase could be recorded.
To determine the relationship between the flow velocities as measured by the two techniques, flow velocity was determined invasively in 10 patients; simultaneously, the linear contrast echo at the tricuspid valve orifice was measured and right ventricular pressure was recorded. In the other four patients, flow velocity and the linear contrast echo at the pulmonic valve orifice were measured simultaneously, and right ventricular pressure was recorded at the same time.
The linear contrast echo that appeared within 120 msec after tricuspid valve opening was used to determine the linear contrast echo angle (0) ( fig. 1) Damping, rejection and gain were controlled during contrast echo recording. The changes in contrast flow velocity were investigated under different respiration and heart rate conditions, as well as during a transient volume increase induced by 5-second, 450 passive rapid elevation of both legs.
Echocardiographic tracings were made on a SmithKline ultrasonoscope (Ekoline 20-A) interfaced with an Electronics for Medicine VR-12 strip-chart recorder. All recordings were made at a paper speed of 100 mm/see.
Results
The linear contrast echo that appeared within 120 msec of tricuspid and pulmonic valve opening was almost a straight line and its angle (0) could be measured accurately ( Figure 2 shows representative simultaneous recordings of the contrast echo at the tricuspid valve orifice, right ventricular pressure, and flow velocity obtained by the probe at the tricuspid valve orifice. The peak flow velocity can be evaluated by the height of the curve. The pattern is very similar to the tricuspid valve motion. By comparison, where the flowvelocity curve is higher, the ratio of a/b is greater, whereas when the flow-velocity curve is lower, the ratio of a/b is smaller ( fig. 2 ). Instantaneous changes in contrast flow velocity and flow velocity as measured by the probe during the simple physiologic maneuvers of respiration and elevation of both legs to increase right ventricular flow were observed. Figure 5 shows representative instantaneous changes in contrast flow velocity as determined by the contrast echo angle and simultaneously recorded flow velocity, measured by the probe, during 5 second, 450 passive rapid elevation of both legs (case 1). Contrast flow-velocity changes coincided with changes in flow velocity measured by the probe. We investigated the relationship between flow-velocity changes as measured by the contrast echo angle and the probe and found a good correlation between the two measurements (table 1; mean r-0.87). Figure 6 shows typical examples of these measurements and their relationships. Figures  6A and B show two of five patients in whom probe values were higher than the contrast echo measurements, figure 6C shows one of two patients in whom the two values were almost equivalent and figure 6D shows one of three patients in whom value measured by the contrast echo was higher than the probe value.
The difference between the measurements obtained by the two procedures was less than 30% in all patients but the one shown in figure 6D . Simultaneous recordings of the contrast echo and intracardiac pressure and flow velocity measured invasively at the pulmonic valve orifice during the different RR intervals in all four patients with atrial fibrillation showed good correlation (mean r = 0.92) between the instantaneous changes in contrast flow velocity and flow velocity measured by the probe at the pulmonic valve orifice (table 1). The findings in case 11 are illustrated in figure 7 . The value measured at the pulmonic valve orifice was in better agreement°'~5 00 c 400- with the flow velocity value than that measured at the tricuspid valve orifice. Figure 4 is a representative simultaneous recording of the contrast echo at the pulmonic valve orifice, right ventricular pressure, and flow velocity obtained by the probe at the pulmonic valve orifice in the same patient with atrial fibrillation. Flow velocity changed according to the different preceding RR intervals. In 12 normal subjects, variability of the contrast flow velocity was within 10% when each subject was assessed two to 10 times over a period of one or several days.
The contrast flow velocity was strongly affected by respiration. Figure 8 shows the contrast echo tracing at the tricuspid valve orifice in a normal subject during respiration. The contrast flow velocity changed during inspiration and expiration. Two vertical lines were drawn at the point of tricuspid valve opening. The contrast flow velocity is fast at deep inspiration and slow at maximal expiration. Figure 9 shows the changes in the heart rate and contrast flow velocity during deep respiration in the same subject. The contrast flow velocity changed with respiratory phase and heart rate. A 10% increase in heart rate produced a 45% average increase in contrast flow velocity, from the control value of 340 mm/sec to a value of 500 mm/sec. Similar results were obtained in all other normal subjects tested. The changes in contrast flow velocity were less than 5% compared with the control level when the subjects held their breath. At the shallowest respiration possible, changes in contrast flow velocity were less than 10% compared with the control level. The contrast flow velocity at the tricuspid valve orifice in 12 normal subjects was 345 ± 30 mm/sec during the shallowest respiration possible. In each case, 450 passive rapid elevation of both legs for 5 seconds effected a change in contrast flow velocity. Contrast flow velocity at deep inspiration is fast (the ratio of a/b is greater), whereas at maximal expiration, it is slow (the ratio of a/b is smaller).
shows the relative changes in contrast flow velocity caused by passive rapid elevation of both legs. The premaneuver values were those recorded 3-5 seconds before leg elevation. One standard deviation of contrast flow velocity was calculated from each cardiac cycle of the 12 normal subjects. Contrast flow velocity began to increase immediately upon elevation of both legs, and the maximal increase during this maneuver averaged 40%. Thereafter, it gradually decreased and returned to the control level within 2 seconds after the legs were lowered to the horizontal position. n is pointed in a direction different from intraHowever, the blood flow through the tricuspid valve liac flow, the flow-velocity pattern obtained is not from the right atrium to the right ventricle may be pletely reliable. multidirectional and may not always be directed le compared flow-velocity measurements simulstraight ahead. Therefore, the geometry of the pul-*ously obtained by using the probe and by the echo monary artery during recording is much more likely to [e. At the pulmonic valve orifice, we when we recorded the linear contrast echo at the tricuspid valve orifice where the ultrasonic beam was directed as described previously, the length of the echo was 2.4 ± 0.6 cm in 60 cases (22 cases in this study and additional 38 cases in another series) who showed a well-defined linear contrast echo. In the 10 patients in whom the flow velocity was recorded simultaneously with the echo trace, the shortest linear contrast echo was 1.5 cm (two cases). However, even in these two cases, flow velocity was underestimated by 29% and 27% when the catheter method was used. Therefore, we considered 1.5 cm the minimum length required to calculate flow velocity using our method. While the absolute value of flow velocity cannot be measured in this situation, it is possible to evaluate the relative changes in flow velocity. In fact, instantaneous changes in contrast flow velocity agreed well with values obtained by the probe (fig. 6 ). We concluded that the linear contrast echo measurement represents a reliable alternative to the catheter method. Accurate recording of the linear contrast echo tracings is severely hampered when the ultrasonic beam is incorrectly angled. In fact, in about half of 45 patients in another series, in whom the linear contrast echo was recorded at the pulmonic valve orifice, it was extremely difficult to position the beam correctly for reasons such as the proximity of the pulmonary artery to the chest wall, which yielded unclear echo tracings. However, in the four patients with dilated pulmonary arteries in the present study, no such problem existed, as the pulmonic valve could easily be located for echocardiographic investigation. By comparison, it was easier to position the beam correctly at the tricuspid valve, and distinct linear contrast echoes were therefore relatively simple to achieve. Indeed, a welldefined linear contrast echo was obtained in more than 80% of the additional 45 patients mentioned above.
The angle of the linear contrast echo is steeper than the opening slope of both the tricuspid and pulmonic valve ( figs. 1 and 3) . If the ultrasonic beam is directed approximately parallel to the microbubbles in midstream blood flow, the angle of the linear contrast echo made by these microbubbles may be taken as the velocity of midstream flow. On the other hand, although the tip of the tricuspid or pulmonic valve is positioned at the midstream at the beginning of valve opening, the tips are pushed away by the stream. Therefore, the opening slope of each valve cannot represent the actual midstream flow velocity and is less steep than the angle of the contrast echo.
Our method is relatively simple and reproducible. In 12 normal subjects, contrast flow velocity varied by 10% or less when assessed in each subject at least twice in a single day and also on different days. When these normal subjects held their breath while the contrast echo was being recorded, there was a difference of less than 5% between the echo angle at the beginning of the breath-holding exercise (control value) and the angles obtained during the subsequent 10 cardiac cycles. These results suggest satisfactory reproducibility and reliability.
To confirm the validity of our method, we evaluated contrast flow-velocity changes at the tricuspid valve orifice caused by respiration and elevation of both legs. Deep inspiration leads to decreased intrathoracic pressure and increased venous return. Using this well-established phenomenon of respiratory effect on the returning blood flow to the right ventricle, we evaluated the changes in contrast flow velocity during respiration. At first, we observed the effect of breathholding on contrast flow velocity and found that there was at most a 5% variation from the control level. As expected, marked changes in contrast flow velocity occurred during deep respiration ( figs. 8 and 9 ). The contrast flow velocity appeared to reflect changes in heart rate and phase of respiration very closely.
Next, we produced an increase in venous return by passive rapid elevation of both legs to determine its effect upon contrast flow velocity. In 12 normal subjects, the maximal increase averaged 40%. Even in the cardiac cycle that showed the greatest patient-topatient difference, 1 standard deviation was still less than 20%. In addition, on return of both legs to the horizontal position, the contrast flow velocity returned to the control level within 2 seconds. These results strongly support the reliability of our method.
We considered the possibility that changes in contrast flow velocity may be induced by changes in the angle of the ultrasonic beam during respiration and elevation of both legs. If the angle of the ultrasonic beam is changed, for example, by body or chest wall motion during the maneuvers, contrast flow velocity may be changed. Therefore, before starting the maneuvers, we repeatedly recorded well-defined linear contrast echoes by directing the beam at the tip of the tricuspid valve as imaged by two-dimensional echocardiography, and measured the fastest possible angle of the contrast echo. Then, if the angle of the ultrasonic beam was changed in relation to the tricuspid valve during maneuvers, it is possible the contrast flow velocity could be decreased, because the angle between the ultrasonic beam and the moving microbubble could be greater than the premaneuver angle. However, during the maneuvers, only an increase in contrast flow velocity compared with the premaneuver level was noted. This suggests that contrast flow velocity may have been underestimated, even though the direction of the ultrasonic beam may not have changed markedly during the maneuvers.
By comparing the relative changes in contrast flow velocity induced by elevation of both legs with the pattern of the normal subjects ( fig. 10) , it was possible to evaluate right ventricular function in terms of flow velocity in patients with heart disease. 27 When we measured the contrast flow velocity at the pulmonic valve rather than the tricuspid valve, the velocity varied depending on the preceding RR interval. After a longer diastole, flow velocity was higher. In our four patients with atrial fibrillation, this relationship was very good and patient 11 gave a typical correlation of 0.92 ( fig. 1 1) .
We conclude that the linear contrast echo obtained by contrast echocardiography is relatively easy to 1415 VOL 63, No 6, JUNE 1981 achieve, reliable and reproducible, and that it facilitates evaluation of instantaneous changes in flow velocity in the right side of the heart, assuming careful attention is given to the techniques of recording and measurement. Absolute flow velocity is more accurately measured for the pulmonary valve than for the tricuspid valve with this method. Changes in flow through either valve can be assessed by this means when interventions are applied.
